- Home
- GF vs CBUS Comparison
GF vs CBUS Comparison
Compare GF & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GF
- CBUS
- Stock Information
- Founded
- GF 1990
- CBUS 2010
- Country
- GF Germany
- CBUS United States
- Employees
- GF N/A
- CBUS N/A
- Industry
- GF Investment Managers
- CBUS Agricultural Chemicals
- Sector
- GF Finance
- CBUS Industrials
- Exchange
- GF Nasdaq
- CBUS Nasdaq
- Market Cap
- GF 126.8M
- CBUS 120.1M
- IPO Year
- GF N/A
- CBUS 2017
- Fundamental
- Price
- GF $8.82
- CBUS $2.08
- Analyst Decision
- GF
- CBUS Strong Buy
- Analyst Count
- GF 0
- CBUS 3
- Target Price
- GF N/A
- CBUS $22.17
- AVG Volume (30 Days)
- GF 28.1K
- CBUS 124.9K
- Earning Date
- GF 01-01-0001
- CBUS 03-20-2025
- Dividend Yield
- GF 0.82%
- CBUS N/A
- EPS Growth
- GF N/A
- CBUS N/A
- EPS
- GF N/A
- CBUS N/A
- Revenue
- GF N/A
- CBUS $4,152,999.00
- Revenue This Year
- GF N/A
- CBUS $132.42
- Revenue Next Year
- GF N/A
- CBUS $97.96
- P/E Ratio
- GF N/A
- CBUS N/A
- Revenue Growth
- GF N/A
- CBUS 449.34
- 52 Week Low
- GF $7.38
- CBUS $2.05
- 52 Week High
- GF $9.41
- CBUS $23.18
- Technical
- Relative Strength Index (RSI)
- GF 67.31
- CBUS 31.98
- Support Level
- GF $8.81
- CBUS $2.39
- Resistance Level
- GF $8.99
- CBUS $2.67
- Average True Range (ATR)
- GF 0.10
- CBUS 0.19
- MACD
- GF 0.03
- CBUS -0.01
- Stochastic Oscillator
- GF 77.33
- CBUS 4.62
About GF New Germany Fund Inc. (The)
NEW GERMANY FUND INC is a United States-based non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.